MEETINGS - Seminars on Selling your Products in the 1990s: Complying with US and International Regulatory Requirements (US) May and July 1995:
This article was originally published in Clinica
The US Health Industry Manufacturers Association (HIMA) is organising two US regional seminars on Selling your Products in the 1990s: Complying with US and International Regulatory Requirements. These will examine US and international regulations, the FDA's inspection priorities and approval process, European Notified Body inspections and product- selling in Europe. The first seminar will be held on May 18th- 19th, 1995, in Minneapolis, MN, and the second on July 13th- 14th, 1995, in Boston, MA. Further details are available from: Laura Fenwick, HIMA, 1200 G Street NW, Suite 400, Washington, DC 2005-3814, US. Tel: +1 (202) 783 8700. Fax: +1 (202) 783 8750.
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.